The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Treatment of Sarcoidosis With Infliximab
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing Agent
Keane, J., Gershon, S., Wise, R. P., Mirabile-Levens, E., Kasznica, J., Schwieterman, W. D., Siegel, J. N., & Braun, M. M. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011110 · Cited by 3,710
Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease
Baert, F., Noman, M., Vermeire, S., Van Assche, G., D' Haens, G., Carbonez, A., & Rutgeerts, P. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa020888 · Cited by 2,015
Kindler, V., Sappino, A.-P., Grau, G. E., Piguet, P.-F., & Vassalli, P. (1989) · Cell · doi:10.1016/0092-8674(89)90676-4 · Cited by 1,254
Roach, D. R., Bean, A. G. D., Demangel, C., France, M. P., Briscoe, H., & Britton, W. J. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.9.4620 · Cited by 782
Yazaki, Y., Isobe, M., Hiroe, M., Morimoto, S.-I., Hiramitsu, S., Nakano, T., Izumi, T., & Sekiguchi, M. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)01978-6 · Cited by 664
Brown, S. L., Greene, M. H., Gershon, S. K., Edwards, E. T., & Braun, M. M. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10679 · Cited by 655
Etanercept for the Treatment of Stage II and III Progressive Pulmonary Sarcoidosis
Utz, J. P., Limper, A. H., Kalra, S., Specks, U., Scott, J. P., Vuk-Pavlovic, Z., & Schroeder, D. R. (2003) · Chest · doi:10.1378/chest.124.1.177 · Cited by 390
Diagnosis and Management of Neurological Sarcoidosis
Lower, E. E. (1997) · Archives of Internal Medicine · doi:10.1001/archinte.157.16.1864 · Cited by 330
Gottlieb, J. E., Israel, H. L., Steiner, R. M., Triolo, J., & Patrick, H. (1997) · Chest · doi:10.1378/chest.111.3.623 · Cited by 310
Current concepts of the pathogenesis of sarcoidosis.
Pd, T., & Hunninghake, G. W. (1987) · PubMed · doi:10.1164/arrd.1987.135.3.747 · Cited by 250
Current Concepts of the Pathogenesis of Sarcoidosis1,2
Thomas, P. D., & Hunninghake, G. W. (2015) · American Review of Respiratory Disease · Cited by 239
Histoplasmosis after Treatment with Anti–Tumor Necrosis Factor-α Therapy
Wood, K. L., Hage, C. A., Knox, K. S., Kleiman, M. B., Sannuti, A., Day, R. B., Wheat, L. J., & Twigg, H. L. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200206-563oc · Cited by 237
Pentoxifylline in treatment of sarcoidosis.
Zabel, P., Entzian, P., Dalhoff, K., & Schlaak, M. (1997) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.155.5.9154873 · Cited by 220
Infliximab for refractory sarcoidosis.
Baughman, R. P., & Lower, E. E. (2001) · PubMed · Cited by 213
Thalidomide for Chronic Sarcoidosis
Baughman, R. P., Judson, M. A., Teirstein, A. S., Moller, D. R., & Lower, E. E. (2002) · Chest · doi:10.1378/chest.122.1.227 · Cited by 194
Self-citationRelease of tumor necrosis factor by alveolar macrophages of patients with sarcoidosis.
Baughman, R. P., Strohofer, S., Buchsbaum, J., & Lower, E. E. (1990) · PubMed · Cited by 165
Refractory Sarcoidosis Responding to Infliximab *
Roberts, S. D., Wilkes, D. S., Burgett, R. A., & Knox, K. S. (2003) · CHEST Journal · doi:10.1378/chest.124.5.2028 · Cited by 121
An Approach to the Treatment of Pulmonary Sarcoidosis With Corticosteroids
Judson, M. A. (1999) · CHEST Journal · doi:10.1378/chest.115.4.1158 · Cited by 113
Self-citationPritchard, C., & Nadarajah, K. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2002.004226 · Cited by 112
Ocular Manifestations of Sarcoidosis
Bradley, D., Baughman, R. P., Raymond, L. A., & Kaufman, A. H. (2002) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-2002-36518 · Cited by 102
Refractory neurosarcoidosis responding to infliximab
Morcos, Z. (2003) · Neurology · doi:10.1212/wnl.60.7.1220-a · Cited by 99
The Pathogenesis and Treatment of Optic Disc Swelling in Neurosarcoidosis
Katz, J. M., Bruno, M. K., Winterkorn, J. M. S., & Nealon, N. (2003) · Archives of Neurology · doi:10.1001/archneur.60.3.426 · Cited by 83
Alveolar Macrophage TNF-Alpha Release and BAL Cell Phenotypes in Sarcoidosis
Zheng, L., Teschler, H., Guzman, J., Hübner, K., Stříž, I., & Costabel, U. (1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.152.3.7663784 · Cited by 82
TREATMENT WITH CORTICOSTEROIDS
Winterbauer, R. H., Kirtland, S. H., & Corley, D. E. (1997) · Clinics in Chest Medicine · doi:10.1016/s0272-5231(05)70422-6 · Cited by 24
Cited by
Infliximab Therapy in Patients with Chronic Sarcoidosis and Pulmonary Involvement
Baughman, R. P., Drent, M., Kavuru, M., Judson, M. A., Costabel, U., du Bois, R., Albera, C., Brutsche, M., Davis, G., Donohue, J. F., et al. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200603-402oc · Cited by 714
Self-citationLevy-Clarke, G., Jabs, D. A., Read, R. W., Rosenbaum, J. T., Vitale, A., & Van Gelder, R. N. (2014) · Ophthalmology · doi:10.1016/j.ophtha.2013.09.048 · Cited by 483
Efficacy of infliximab in extrapulmonary sarcoidosis: results from a randomised trial
Judson, M. A., Baughman, R. P., Costabel, U., Flavin, S., Lo, K. H., Kavuru, M. S., Drent, M., & the Centocor T48 Sarcoidosis investigators (2008) · European Respiratory Journal · doi:10.1183/09031936.00051907 · Cited by 324
Self-citationThe Clinical Features of Sarcoidosis: A Comprehensive Review
Judson, M. A. (2015) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-014-8450-y · Cited by 281
“However, bone involvement of the digits and vertebral bodies may cause significant pain and warrant therapy [195–197].”
BackgroundSelf-citationWinthrop, K. L. (2006) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0336 · Cited by 280
Metadata
- Authors
- Doty, J. D., Mazur, J. E., & Judson, M. A.
- Venue
- Chest
- Publisher
- Elsevier BV
- Published
- 2005-03
- Volume
- 127
- Issue
- 3
- Pages
- 1064-1071
- ISSN
- 0012-3692 (ISSN-L)
- OpenAlex
- W2154811627
- Cited by
- 312
- References
- 24
- FWCI
- 16.97
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.